微流體設備市場規模、佔有率、成長分析（按產品、材料、應用、最終用戶和地區）- 2025-2032 年產業預測

預計到 2023 年全球微流體設備市場規模將達到 244.8 億美元，從 2024 年的 276.1 億美元成長到 2032 年的 723.8 億美元，預測期內（2025-2032 年）的複合年成長率為 12.8%。

全球微流體設備市場經歷了顯著的成長，預計未來將繼續加速成長。這些創新工具對於醫療保健、製藥、生物技術和研究實驗室等多個領域都至關重要。這些工具可以輕鬆建立緊湊、可攜式且經濟高效的診斷解決方案，並提供快速、準確的結果。微流體設備將樣品製備、分析和檢測功能整合到單一平台，使其特別適合在偏遠、資源有限的地區使用。在醫療保健領域，它透過縮小測試過程並減少所需的樣本和試劑量，徹底改變了醫療診斷。因此，基於微流體的檢測技術正在提高檢測的速度、效率和成本效益，促進其在分子診斷、免疫測定、細胞分析和基因組學中的應用，從而顯著增加市場需求。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 次要和資料資料
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 原料分析

微流體設備市場規模（依產品）

• 市場概況
• 基於微流體的設備
• 微流體元件
  • 微流體晶片
  • 流量和壓力感測器
  • 流量和壓力控制器
  • 微流體閥
  • 微型幫浦
  • 微型針
  • 其他組件

微流體設備市場規模（依材料）

• 市場概況
• 玻璃
• 矽
• 聚合物
• 其他

微流體設備市場規模（依應用）

• 市場概況
• 體外診斷
  • 臨床診斷
  • 就地檢驗
  • 獸醫診斷
• 製藥與生命科學研究與製造
  • 實驗室分析
  • 微量點膠
  • 微反應
• 治療
  • 藥物輸送
  • 穿戴式裝置

微流體設備市場規模（依最終用戶分類）

• 市場概況
• 製藥和生物技術公司
• 研究組織
• 診斷中心
• 醫療保健設施等

微流體設備市場規模

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分析市場佔有率
  • 收益與前一年同期比較（2022-2024 年）

主要企業簡介

• Bio-Rad Laboratories（USA）
• Illumina（USA）
• PerkinElmer（USA）
• Abbott Laboratories（USA）
• Thermo Fisher Scientific（USA）
• bioMerieux（France）
• Danaher Corporation（USA）
• Agilent Technologies（USA）
• Sphere Fluidics（UK）
• Standard BioTools（formerly Fluidigm Corporation）（USA）
• BD（Becton, Dickinson and Company）（USA）
• IDEX Corporation（USA）
• SMC Corporation（Japan）
• Parker Hannifin Corporation（USA）
• Fortive Corporation（USA）
• Aignep SpA（Italy）
• Lonza Group（Switzerland）
• Emulate（USA）
• Dolomite Bio（UK）

結論和建議

Global Microfluidic Devices Market size was valued at USD 24.48 billion in 2023 and is poised to grow from USD 27.61 billion in 2024 to USD 72.38 billion by 2032, growing at a CAGR of 12.8% during the forecast period (2025-2032).

The global microfluidic devices market is experiencing remarkable growth, projected to accelerate further. These innovative tools are essential across various sectors, including healthcare, pharmaceuticals, biotechnology, and research labs. They facilitate the creation of compact, portable, and cost-effective diagnostic solutions that provide rapid, accurate results. By integrating functions like sample preparation, analysis, and detection onto a single platform, microfluidic devices are particularly suited for resource-limited and remote settings. The healthcare sector has been a key adopter, transforming medical diagnostics through the miniaturization of laboratory processes and minimizing sample and reagent requirements. Consequently, microfluidic-based assays enhance testing speed, efficiency, and cost-effectiveness, driving their use in molecular diagnostics, immunoassays, cell analysis, and genomics, thereby significantly increasing market demand.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Microfluidic Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Microfluidic Devices Market Segmental Analysis

Global Microfluidic Devices Market is segmented by Product, Material, Application, End User and region. Based on Product, the market is segmented into Microfluidic-based Devices and Microfluidic Components. Based on Material, the market is segmented into Glass, Silicon, Polymer and Others. Based on Application, the market is segmented into In-vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics. Based on End User, the market is segmented into Pharmaceutical and Biotechnology Companies, Research Institutes, Diagnostic Centers and Healthcare Facilities and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Microfluidic Devices Market

The Global Microfluidic Devices market is experiencing significant growth driven by the rising demand for compact and portable solutions across multiple industries such as healthcare, pharmaceuticals, and biotechnology. These devices are ideally positioned to address this need due to their small footprint, which allows for reduced sample consumption and the integration of various functions into a single device. Their capability to execute intricate laboratory procedures on a miniature scale, coupled with the convenience of portability and the ability for on-site analysis, has led to increased adoption. This trend is propelling the expansion of the microfluidic devices market as it caters to evolving application demands.

Restraints in the Global Microfluidic Devices Market

The global microfluidic devices market faces certain restraints primarily due to limited awareness and slow adoption in various industries beyond healthcare and diagnostics. Sectors such as agriculture, environmental monitoring, and food testing, which stand to benefit significantly from microfluidic technologies, tend to adopt these innovations at a slower pace. This lag is often attributed to inadequate awareness, insufficient infrastructure, and a strong reliance on traditional methods. To foster market growth, it is essential to enhance awareness and educate potential end-users about the diverse advantages and applications of microfluidic devices across these underserved industries.

Market Trends of the Global Microfluidic Devices Market

The Global Microfluidic Devices market is witnessing a robust trend toward the increased adoption of point-of-care testing (POCT) applications, driven by the growing demand for rapid and accurate diagnostic solutions. Microfluidic technology facilitates immediate testing at or near the patient, enabling healthcare professionals to make swift decisions based on real-time data. The ability to manage small sample volumes, coupled with their portable and user-friendly design, positions these devices favorably across diverse healthcare environments such as hospitals, clinics, and even home care settings. This trend is particularly significant in emergency and critical care scenarios, underscoring the vital role of microfluidics in enhancing patient outcomes.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Raw Material Analysis

Global Microfluidic Devices Market Size by Product & CAGR (2025-2032)

• Market Overview
• Microfluidic-based Devices
• Microfluidic Components
  • Microfluidic Chips
  • Flow & Pressure Sensors
  • Flow & Pressure Controllers
  • Microfluidic Valves
  • Micropumps
  • Microneedles
  • Other Components

Global Microfluidic Devices Market Size by Material & CAGR (2025-2032)

• Market Overview
• Glass
• Silicon
• Polymer
• Others

Global Microfluidic Devices Market Size by Application & CAGR (2025-2032)

• Market Overview
• In-vitro Diagnostics
  • Clinical Diagnostics
  • Point-of-care Testing
  • Veterinary Diagnostics
• Pharmaceutical & Life Science Research and Manufacturing
  • Lab Analytics
  • Microdispensing
  • Microreaction
• Therapeutics
  • Drug Delivery
  • Wearables Devices

Global Microfluidic Devices Market Size by End User & CAGR (2025-2032)

• Market Overview
• Pharmaceutical and Biotechnology Companies
• Research Institutes
• Diagnostic Centers
• Healthcare Facilities and Others

Global Microfluidic Devices Market Size & CAGR (2025-2032)

• North America (Product, Material, Application, End User)
  • US
  • Canada
• Europe (Product, Material, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Material, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Material, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Material, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Bio-Rad Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sphere Fluidics (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Standard BioTools (formerly Fluidigm Corporation) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BD (Becton, Dickinson and Company) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IDEX Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SMC Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Parker Hannifin Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fortive Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aignep S.p.A (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Emulate (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dolomite Bio (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations